Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 46 (10%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 376 (84%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (18%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SERTRALINE | 50MG | CAPSULE | Resolved | 2023-11-22 | 2023-12-01 | 211074 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2023-11-22 | 2024-01-17 | 211081 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2023-11-22 | 2023-12-26 | 211086 |
| MYCOPHENOLATE MOFETIL | 500MG | TABLET | Resolved | 2023-11-22 | 2023-12-26 | 211089 |
| TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-11-22 | 2024-04-05 | 211102 |
| TRAZODONE | 150MG | TABLET | Resolved | 2023-11-22 | 2023-12-26 | 211117 |
| CIPROFLOXACIN | 250MG | TABLET | Actual shortage | 2023-11-22 | 2024-04-29 | 211197 |
| CIPROFLOXACIN | 500MG | TABLET | Actual shortage | 2023-11-22 | 2024-05-03 | 211200 |
| BACLOFEN | 10MG | TABLET | Avoided shortage | 2023-12-01 | 2023-12-01 | 212107 |
| RABEPRAZOLE EC | 10MG | TABLET (ENTERIC-COATED) | Actual shortage | 2023-12-26 | 2024-05-08 | 214284 |
| PERINDOPRIL ERBUMINE | 8MG | TABLET | Resolved | 2024-01-17 | 2024-02-15 | 216247 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-01-17 | 2024-05-17 | 216254 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-01-17 | 2024-02-13 | 216259 |
| SERTRALINE | 25MG | CAPSULE | Resolved | 2024-01-17 | 2024-05-17 | 216264 |
| SERTRALINE | 50MG | CAPSULE | Actual shortage | 2024-01-17 | 2024-01-30 | 216267 |
| CANDESARTAN | 16MG | TABLET | Actual shortage | 2024-01-17 | 2024-03-07 | 216273 |
| LEVETIRACETAM | 500MG | TABLET | Resolved | 2024-01-17 | 2024-04-11 | 216276 |
| RABEPRAZOLE EC | 20MG | TABLET (ENTERIC-COATED) | Actual shortage | 2024-01-17 | 2024-01-30 | 216283 |
| TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-17 | 2024-02-29 | 216290 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2024-01-30 | 2024-03-14 | 217766 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
| SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |